AGL:NYE-agilon health Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 17.08

Change

-0.70 (-3.94)%

Market Cap

USD 7.03B

Volume

2.04M

Avg Analyst Target

USD 30.88 (+80.77%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

AGL Stock Forecast & Price:
Based on the agilon health Inc stock forecasts from 6 analysts, the average analyst target price for agilon health Inc is USD 30.88 over the next 12 months. agilon health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of agilon health Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, agilon health Inc’s stock price was USD 17.08. agilon health Inc’s stock price has changed by -2.73% over the past week, -2.06% over the past month and -27.04% over the last year.

About agilon health Inc (AGL:NYE)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-f ...Read More

Company Website : https://agilonhealth.com

Address : 6210 East US Highway 290, Austin, TX, United States, 78723

Employees : 646

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

52 Week High : 28.36

Short Ratio : 12.51

52 Week Low : 14.36

Shorted Shares : 23,188,440

200 Day Moving Average : 21.44

Shorted Shares Previous Month : 22,722,124

50 Day Moving Average : 19.78

Shares Held By Insiders : 1.11%

Short Percentage : 14.41%

Shares Held by Institutions : 98.82%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Holdings Inc

+1.49 (+0.63%)

 USD67.94B 13.37 8.49
FMS Fresenius Medical Care Corpora..

+0.23 (+1.48%)

 USD9.51B 11.34 6.63
UHS Universal Health Services Inc

+0.17 (+0.13%)

 USD9.14B 13.19 8.87
CHE Chemed Corp

-1.11 (-0.21%)

 USD7.73B 30.22 19.61
DVA DaVita HealthCare Partners Inc

+1.00 (+1.35%)

 USD6.62B 10.93 8.41
EHC Encompass Health Corp

-0.14 (-0.25%)

 USD5.79B 16.76 8.51
OSH Oak Street Health Inc

+0.28 (+1.33%)

 USD5.33B N/A -12.71
AMN AMN Healthcare Services Inc

+1.22 (+1.04%)

 USD5.10B 16.15 7.38
THC Tenet Healthcare Corporation

+0.45 (+1.03%)

 USD4.73B 8.42 5.74
SEM Select Medical Holdings

-0.80 (-3.30%)

 USD3.09B 17.61 12.77

ETFs Containing AGL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.74% 44% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.74% 44% F 15% F
Trailing 12 Months  
Capital Gain -27.90% 64% D 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.90% 64% D 23% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -12.28% 22% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.28% 17% F 7% F
Risk Return Profile  
Volatility (Standard Deviation) 17.23% 91% A- 64% D
Risk Adjusted Return -71.29% 9% F 5% F
Market Capitalization 7.03B 85% B 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 6.88 29% F 10% F
Price / Cash Flow Ratio -47.48 100% A+ 91% A-
EV/EBITDA -73.05 96% A 94% A
Management Effectiveness  
Return on Equity -9.78% 27% F 20% F
Return on Invested Capital -85.17% 4% F 3% F
Return on Assets -3.39% 12% F 13% F
Debt to Equity Ratio 3.98% 78% C+ 89% B+
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 12.51 4% F 3% F
Short Percent 14.41% 13% F 24% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

New Post

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment
Stock Target Advisor

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector